Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation

Stress is a major risk factor for the development of mood and anxiety disorders; elucidation of novel approaches to mitigate the deleterious effects of stress could have broad clinical applications. Pharmacological augmentation of central endogenous cannabinoid (eCB) signaling may be an effective th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bluett, R J, Gamble-George, J C, Hermanson, D J, Hartley, N D, Marnett, L J, Patel, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119220/
https://www.ncbi.nlm.nih.gov/pubmed/25004388
http://dx.doi.org/10.1038/tp.2014.53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119220/
https://www.ncbi.nlm.nih.gov/pubmed/25004388
http://dx.doi.org/10.1038/tp.2014.53

Ejemplares similares